Neuroimaging techniques used in diagnosing AD and to aid in the differential diagnosis include CT (computed tomography), MRI (magnetic resonance imaging), FDG-PET (fluorodeoxyglucose positron emission tomography), dopamine transporter (DaT) Scan, and amyloid PET scanning. This evidence concerns the gene SLC6A3 and Alzheimer disease.